# Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients

> **NCT00239018** · PHASE4 · COMPLETED · sponsor: **Novartis** · enrollment: 144 (actual)

## Conditions studied

- De Novo Kidney Transplantation

## Interventions

- **DRUG:** Enteric-Coated Mycophenolate Sodium (EC-MPS)

## Key facts

- **NCT ID:** NCT00239018
- **Lead sponsor:** Novartis
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2003-04
- **Primary completion:** 2005-07
- **Final completion:** 2005-07
- **Target enrollment:** 144 (ACTUAL)
- **Last updated:** 2011-01-31


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00239018

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00239018, "Extension Study on the Efficacy and Safety of Enteric-coated Mycophenolate Sodium Administered in de Novo Kidney Transplant Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00239018. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*